Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Development and characterization of nanobodies that specifically target the oncogenic Phosphatase of Regenerating Liver-3 (PRL-3) and impact its interaction with a known binding partner, CNNM3

PLoS ONE(2023)10.1371/journal.pone.0285964Source: DataRank Database

Development and characterization of nanobodies that specifically target the oncogenic Phosphatase of Regenerating Liver-3 (PRL-3) and impact its interaction with a known binding partner, CNNM3 is a research paper published in PLoS ONE (2023). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

Linked data & code

gen nct pdb doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.65)OA: goldTopics (34)IDs (PubMed, PMC, OpenAlex)Annotations (4)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Kyle C. Kihn ORCID,Zachary A. Williamson ORCID,K. Martin Chow,Louis B. Hersh,Konstantin V. Korotkov ORCID

Live enrichment

PubMed:37220097 PMC:PMC10204944 OpenAlex:https://openalex.org/W4377862302

National Cancer Institute

Grant: R37CA227656

National Cancer Institute

Grant: DP2CA228043

National Cancer Institute

Grant: P30CA177558

National Institutes of Health

Grant: 1DP2CA228043-01

Harnessing Single Cell Technology to Define Self-Renewal in Normal and Malignant Stem Cells

National Institutes of Health

Grant: 3P30CA177558-01S1

CTRP Supplement

National Institutes of Health

Grant: 5R37CA227656-04

The phosphatase PRL3 as a MYC target and pro-survival oncogene in Acute Lymphoblastic Leukemia

FWCI

0.65

Citation Percentile

0.6%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0285964&type=printable

publisherhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0285964&type=printable

publisherhttps://dx.plos.org/10.1371/journal.pone.0285964

journalhttps://doi.org/10.1371/journal.pone.0285964

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37220097

Fields of Study

Protein Tyrosine PhosphatasesGalectins and Cancer BiologyGlycosylation and Glycoproteins Research

MeSH Terms

AnimalsAntibodiesCamelids, New WorldDisease Models, AnimalNeoplasmsMiceSingle-Domain Antibodies

Keywords

ImmunoprecipitationPhosphataseCell biologySubcellular localizationBiologyProtein–protein interactionPlasma protein bindingChemistryAntibodyPhosphorylationGeneticsCytoplasmMiceDisease Models, AnimalScienceNeoplasmsQRMedicineAnimalsSingle-Domain AntibodiesCamelids, New WorldAntibodiesResearch Article

Development and characterization of nanobodies that specifically target the oncogenic Phosphatase of Regenerating Liver-3 (PRL-3) and impact its interaction with a known binding partner, CNNM3

FAIR Checklist

Authors (8)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)